Pediatrics
Feature
Texas reports local Zika transmission
On Nov. 28, public health officials reported a case of Zika virus in a Brownsville woman who hadn’t traveled to Mexico or any other area with...
Feature
Fighting back against psoriasis bullies
Dallas dermatologist Alan Menter, MD, doesn’t boast bullying-prevention superpowers, but what he does have is close enough: An eagerness to get...
Conference Coverage
The eyelids have it: bug bites 101
NEWPORT BEACH, CA. – Bed bugs rise when night falls. Drawn by the carbon dioxide of sleeping humans, they gather to feast, leaving bites galore....
From the Journals
Infants with congenital Zika born without microcephaly still can still develop it
Head circumferences of 13 Brazilian infants – born with confirmed congenital Zika virus but without microcephaly – shrunk within 1 year.
From the Journals
Two doses of HPV vaccine may be noninferior to three
The immunogenicity response to two doses of the 9-valent HPV vaccine in children and adolescents was noninferior to the immunogenicity of the...
Conference Coverage
Clindamycin, TMP-SMX both of benefit for small abscesses
Both clindamycin and trimethoprim-sulfamethoxazole were superior to placebo when used after incision and drainage for the treatment of small,...
From the Journals
Low parental confidence in HPV vaccine stymies adolescent vaccination rates
More than a quarter of U.S. parents surveyed refused human papillomavirus vaccination in their adolescents because of a lack of overall trust in...
News from the FDA/CDC
FDA: Etanercept first biologic approved for pediatric psoriasis
Etanercept has been approved for treating children and adolescents, aged 4-17 years, with chronic moderate to severe plaque psoriasis.
News from the FDA/CDC
Large increase seen in number of Zika-infected pregnancies
The 288 new cases of pregnant women with laboratory evidence of Zika infection reported for the week ending Oct. 27, 2016, represent the largest...
Conference Coverage
Topical crisaborole boosts quality of life in atopic dermatitis
VIENNA – Topical crisaborole 2% ointment twice a day was consistently associated with clinically meaningful quality of life improvement scores on...
Conference Coverage
Lyme disease spirochete helps babesiosis gain a foothold
BOSTON – The spirochete that causes Lyme disease in humans may be helping to escalate the rate of human babesiosis cases in regions where both are...